Contact this trialFirst, we need to learn more about you.
Antisense Oligonucleotide
WVE-003 for Huntington's Disease
Recruiting1 awardPhase 1 & 2
Edmonton, Alberta
This trial is testing a new drug called WVE-003 in adults with early-stage Huntington's Disease who have a specific genetic marker. The goal is to see if the drug is safe and effective by changing how certain genes work.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.